PAPER Leissring MA, Turner AJ
SEARCH RESULTS
329967 RESULTS
PAPER Ossenkoppele R, Prins ND, van Berckel BN
Amyloid imaging in clinical trials.
Alzheimers Res Ther. 2013 Aug 14;5(4):36. PubMed: 23953396PAPER Nakanishi M, Nakashima T
Features of the Japanese national dementia strategy in comparison with international dementia policies: How should a national dementia policy interact with the public health- and social-care systems?
Alzheimers Dement. 2013 Aug 14; PubMed: 23954026PAPER Foster PS, Roosa KM, Williams MR, Witt JC, Heilman KM, Drago V
Immunological functioning in Alzheimer's disease: Differential effects of relative left versus right temporoparietal dysfunction.
J Neuroimmunol. 2013 Oct 15;263(1-2):128-32. PubMed: 23953971PAPER Obermann KR, Morris JC, Roe CM
Exploration of 100 commonly used drugs and supplements on cognition in older adults.
Alzheimers Dement. 2013 Aug 14; PubMed: 23954027PAPER Alpérovitch A, Blachier M, Soumaré A, Ritchie K, Dartigues JF, Richard-Harston S, Tzourio C
Blood pressure variability and risk of dementia in an elderly cohort, the Three-City Study.
Alzheimers Dement. 2013 Aug 14; PubMed: 23954028PAPER Leoutsakos JM, Bartlett AL, Forrester SN, Lyketsos CG
Simulating effects of biomarker enrichment on Alzheimer's prevention trials: Conceptual framework and example.
Alzheimers Dement. 2013 Aug 14; PubMed: 23954029PAPER Wray LO, Wade M, Beehler GP, Hershey LA, Vair CL
A Program to Improve Detection of Undiagnosed Dementia in Primary Care and Its Association with Healthcare Utilization.
Am J Geriatr Psychiatry. 2013 Aug 13; PubMed: 23954037PAPER Hahn EA, Wang HX, Andel R, Fratiglioni L
A Change in Sleep Pattern May Predict Alzheimer Disease.
Am J Geriatr Psychiatry. 2013 Aug 13; PubMed: 23954041PAPER Ebbert MT, Ridge PG, Wilson AR, Sharp AR, Bailey M, Norton MC, Tschanz JT, Munger RG, Corcoran CD, Kauwe JS
Population-based Analysis of Alzheimer's Disease Risk Alleles Implicates Genetic Interactions.
Biol Psychiatry. 2013 Aug 13; PubMed: 23954108PAPER Ghosh D, Levault KR, Brewer GJ
Dual-energy precursor and nuclear erythroid-related factor 2 activator treatment additively improve redox glutathione levels and neuron survival in aging and Alzheimer mouse neurons upstream of reactive oxygen species.
Neurobiol Aging. 2014 Jan;35(1):179-90. PubMed: 23954169PAPER Ohno M, Hiraoka Y, Lichtenthaler SF, Nishi K, Saijo S, Matsuoka T, Tomimoto H, Araki W, Takahashi R, Kita T, Kimura T, Nishi E
Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model.
Neurobiol Aging. 2014 Jan;35(1):213-22. PubMed: 23954170PAPER Papadopoulos P, Tong XK, Hamel E
Selective benefits of simvastatin in bitransgenic APPSwe,Ind/TGF-β1 mice.
Neurobiol Aging. 2014 Jan;35(1):203-12. Epub 2013 Aug 15 PubMed: 23954171PAPER Liu YH, Zeng F, Wang YR, Zhou HD, Giunta B, Tan J, Wang YJ
Immunity and Alzheimer's disease: immunological perspectives on the development of novel therapies.
Drug Discov Today. 2013 Aug 13; PubMed: 23954180PAPER Mehta DC, Short JL, Nicolazzo JA
Reduced CNS exposure of memantine in a triple transgenic mouse model of Alzheimer's disease assessed using a novel LC-MS technique.
J Pharm Biomed Anal. 2013 Nov;85:198-206. PubMed: 23954439Current Filters
No filters selected